About Us

We are a multi-disciplinary team of pathologists, biologists, analysts, software engineers, and technicians who are committed to creating successful approaches which match patients with life-saving drugs.
Upcoming Conference: Visit us at the Next Generation Dx Summit 2017 - Booth #415

Helping Biomedical Companies
Change Lives.

Flagship leverages contextual tissue biomarkers to accelerate drug development
with confident, data-driven decisions.

Key Facts:

  • Largest clinical tissue-image-analysis operation in the world
  • Exclusively serving pharma and biotech with our patented technology
  • Integrated scientific team delivers optimal data for decision making
  • Technology for quantitative and comprehensive data in tissue context
  • Clinically implemented technology in a scalable, efficient operation
  • Over 400 projects completed for over 100 clients since 2009

Our Leadership

Holger Lange, PhD
Chief Technology Officer
Joseph Krueger, PhD
Chief Scientific Officer
Trevor Johnson, MS
Chief Operating Officer
Dean Northey
Chief Financial Officer
Our Facilities

Our experts are focused on delivering your success in our integrated wet assay and image analysis laboratories.

State of the art histology laboratory

State of the art histology laboratory

Advanced tissue image analysis laboratory

Advanced tissue image analysis laboratory

High-throughput analysis capabilities

High-throughput analysis capabilities

Brightfield and fluorescent whole slide scanning

Brightfield and fluorescent whole slide scanning

Flexibility on multiple platforms

Flexibility on multiple platforms

CLIA certified laboratory

CLIA certified laboratory

Recent Posters

Our technology enables us to create custom image analysis approaches for even the most difficult pathology endpoints. Our software is developed through our experience in real world applications, supported by an internal research and development team, and is backed by our intellectual property portfolio.

Professional Organizations

We are involved and contribute to the advancement of our field through professional participation.

Over 100 pharmaceutical, biotech, and medical device firms rely on Flagship's technology for success.

Our combination of biology, pathology, and technology has advanced emerging therapies in over 400 studies.